Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	[1]	$ 41,623	$ 34,928
General and administrative	[2]	11,944	12,846
Total operating expenses		53,567	47,774
Loss from operations		(53,567)	(47,774)
Other income:
Interest income		6,493	4,432
Other income (expense), net		2,286	(483)
Total other income		8,779	3,949
Loss before income tax expense		(44,788)	(43,825)
Income tax benefit (expense)		15	(32)
Net loss		(44,773)	(43,857)
Series A Non Voting Convertible Preferred Stock
Other income:
Net loss		$ (8,288)	$ (12,642)
Net loss per share, basic (in dollars per share)		$ (23.95)	$ (28.93)
Net loss per share, diluted (in dollars per share)		$ (23.95)	$ (28.93)
Weighted-average common stock outstanding, basic (in shares)		346,045	437,037
Weighted-average common stock outstanding, diluted (in shares)		346,045	437,037
Series B Non Voting Convertible Preferred Stock
Other income:
Net loss		$ (399)	$ (4,810)
Net loss per share, basic (in dollars per share)		$ (23.95)	$ (28.93)
Net loss per share, diluted (in dollars per share)		$ (23.95)	$ (28.93)
Weighted-average common stock outstanding, basic (in shares)		16,667	166,261
Weighted-average common stock outstanding, diluted (in shares)		16,667	166,261
Common Stock
Other income:
Net loss		$ (36,086)	$ (26,405)
Net loss per share, basic (in dollars per share)		$ (0.60)	$ (0.72)
Net loss per share, diluted (in dollars per share)		$ (0.60)	$ (0.72)
Weighted-average common stock outstanding, basic (in shares)		60,265,932	36,512,662
Weighted-average common stock outstanding, diluted (in shares)		60,265,932	36,512,662

[1] Includes $2.5 million and $17.1 million in related party expenses for the three months ended March 31, 2025 and 2024, respectively.

[2] Includes $0.3 million in related party expenses for the three months ended March 31, 2025 and 2024.